Ethan Burns
Overview
Explore the profile of Ethan Burns including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molecular Signatures of -Mutated Lung Adenocarcinoma: Analysis of Concomitant , , , and PD-L1 Status
Hsu J, Annunziata J, Burns E, Bernicker E, Olsen R, Thomas J
Clin Pathol
. 2022 May;
15:2632010X221102054.
PMID: 35634237
Background: mutations are the most common oncogenic driver mutations of non-small cell lung cancer (NSCLC) in the Western world. Mutations of the gene are most prevalent in the patient population...
2.
Kasparian S, Gentille C, Burns E, Bernicker E
JTO Clin Res Rep
. 2021 Sep;
1(2):100017.
PMID: 34589924
Introduction: Immune-checkpoint inhibitors (ICIs) are transforming the modern era of cancer therapy. As new treatment options are becoming available, new patterns of disease behavior are manifesting. One such phenomenon, known...
3.
Yu K, Hendifar A, Alese O, Draper A, Abdelrahim M, Burns E, et al.
Front Oncol
. 2021 Aug;
11:678070.
PMID: 34336666
Background: The NAPOLI-1 trial demonstrated that liposomal irinotecan in combination with fluorouracil (5-FU) and leucovorin (LV) prolonged survival with a manageable safety profile in patients with metastatic pancreatic ductal adenocarcinoma...
4.
Burns E, Koca E, Xu J, McLean E, Lee R, Patel T, et al.
Oncologist
. 2021 Feb;
26(6):e936-e942.
PMID: 33594769
Purpose: This study evaluated the proportion of premenopausal women who experience persistent ovarian escape (OE) while receiving ovarian suppression (OS) therapy for estrogen receptor-positive (ER+) breast cancer treatment. The study...
5.
Anand K, Sahu G, Burns E, Ensor A, Ensor J, Pingali S, et al.
ESMO Open
. 2020 Aug;
5(4).
PMID: 32817069
Background: Immune checkpoint inhibitors that block programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have improved outcomes for many cancer subtypes but do exhibit toxicity, in the form...
6.
Kasparian S, Burns E, Shehabeldin A, Awar M, Pingali S
J Med Case Rep
. 2020 Aug;
14(1):127.
PMID: 32782017
Background: Acute small bowel obstruction is a common surgical emergency usually caused by abdominal adhesions, followed by intraluminal tumors from metastatic disease. Although lymphomas have been known to cause bowel...
7.
Ahmed A, Granillo A, Burns E, Glassner K, Naseem N, Force C, et al.
Case Rep Med
. 2020 Mar;
2020:8613840.
PMID: 32148514
Herpes simplex virus (HSV) is a rare cause of hepatitis in pregnancy and the chronically immunosuppressed, with a high propensity to progress to acute liver failure (ALF) and death. Patients...
8.
Kasparian S, Anand K, Burns E, Chung B, Pingali S
Cureus
. 2019 Aug;
11(6):e4929.
PMID: 31431835
Hemophagocytic lymphohistiocytosis (HLH) due to an underlying rheumatologic condition is known as macrophage activation syndrome (MAS), a rare and serious complication that often has a delayed diagnosis. MAS can complicate...
9.
Ewing D, Brozovich A, Burns E, Acosta G, Hatcher C, Patel P, et al.
Case Rep Gastrointest Med
. 2019 May;
2019:1790686.
PMID: 31139476
Iron deficiency is the most common etiology of anemia worldwide and is often managed with varying methods of iron supplementation. Although rare, oral iron supplementation can perpetuate iron deficiency anemia...
10.
Brozovich A, Ewing D, Burns E, Hatcher C, Acosta G, Khan U, et al.
Case Rep Oncol Med
. 2019 May;
2019:2671794.
PMID: 31093392
A 65-year-old male with a history of ischemic strokes, seizures, and subarachnoid hemorrhage presented with a 4-week history of progressive diplopia, vertigo, nausea, and vomiting. Magnetic resonance imaging (MRI) revealed...